Featured Research

from universities, journals, and other organizations

MGH Researchers Unravel Structure Of A Key Protein Involved In Tumor Angiogenesis And Metastasis

Date:
March 13, 2002
Source:
Massachusetts General Hospital
Summary:
Cancer cells need a blood supply to grow. A key receptor protein called the alpha V beta 3 integrin directs formation of new blood vessels by binding to other proteins, such as angiostatin and endostatin, produced by tumor cells. Scientists at Massachusetts General Hospital (MGH) have now deciphered the detailed structure of this protein as it interacts with its ligand (the protein that binds to a receptor). The work comes on the heels of findings published last year by the MGH investigators on the structure of the same protein in its resting unbound state.

Cancer cells need a blood supply to grow. A key receptor protein called the alpha V beta 3 integrin directs formation of new blood vessels by binding to other proteins, such as angiostatin and endostatin, produced by tumor cells. Scientists at Massachusetts General Hospital (MGH) have now deciphered the detailed structure of this protein as it interacts with its ligand (the protein that binds to a receptor). The work comes on the heels of findings published last year by the MGH investigators on the structure of the same protein in its resting unbound state. The new data, which will appear in a future issue of Science, are being published March 7 on the Science Express website (http://www.sciencexpress.org).

"By knowing the intricate molecular interactions between this receptor and its ligand, we are now in a better position to devise inhibitors that block this interaction and therefore prevent or forestall tumor angiogenesis and progression," says M. Amin Arnaout, MD, senior author, director of the MGH Structural Biology Program and chief of the MGH Renal Unit. Arnaout says this integrin receptor is also used by breast cancer cells to escape into the bloodstream and metastasize. "With this new information, we might be able to intercept that process as well," says Arnaout.

The MGH scientists also found that alpha V beta 3 integrin changes its shape when bound to its ligand, allowing it to send chemical signals instructing tumor cells to grow and spread. "Defining this shape-shift at the atomic level may also be harnessed therapeutically by designing more selective drugs with fewer side effects," says Arnaout.

There are 23 additional integrin receptors in humans, all with similar structural motifs. Some of these play important roles in other diseases -- such as osteoporosis, stroke, heart attack, diabetes, nephritis and rheumatoid arthritis -- and all bind to their protein ligands in a similar manner. "Catching an integrin in the act of binding to its ligand will offer new means of developing drugs to other debilitating diseases besides cancer," says Arnaout.

The other members of the research team include Jian-Ping Xiong, PhD, and Thilo Stehle, PhD, of the MGH -- who along with Arnaout are members of the MGH Structural Biology Program -- Matthias Frech, PhD, and Simon Goodman, PhD, of Merck KGaA in Germany, and Rongguang Zhang, PhD, and Andrzej Joachimiak, PhD, of the Argonne National Laboratory in Illinois. The study was supported by research grants from the National Institutes of Health and the U.S. Department of Energy.

The Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $300 million and major research centers in AIDS, the neurosciences, cardiovascular research, cancer, cutaneous biology, transplantation biology and photomedicine. In 1994, the MGH joined with Brigham and Women's Hospital to form Partners HealthCare System, an integrated health care delivery system comprising the two academic medical centers, specialty and community hospitals, a network of physician groups and nonacute and home health services.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts General Hospital. "MGH Researchers Unravel Structure Of A Key Protein Involved In Tumor Angiogenesis And Metastasis." ScienceDaily. ScienceDaily, 13 March 2002. <www.sciencedaily.com/releases/2002/03/020311080220.htm>.
Massachusetts General Hospital. (2002, March 13). MGH Researchers Unravel Structure Of A Key Protein Involved In Tumor Angiogenesis And Metastasis. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2002/03/020311080220.htm
Massachusetts General Hospital. "MGH Researchers Unravel Structure Of A Key Protein Involved In Tumor Angiogenesis And Metastasis." ScienceDaily. www.sciencedaily.com/releases/2002/03/020311080220.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins